FDA & Government News

June 04, 2026

HHS Seeks Broader Access to Health Data

"We can’t do anything our agreements don’t allow us to do"

Kff Health News

June 03, 2026

Hospital AI Fails to Flag Drug Diversion

"I've never myself seen these technologies be called out in that specific way"

Kff Health News

June 02, 2026

ADHD Drug CTx-1301 Receives Complete Response Letter

Company says the agency requested additional Chemistry, Manufacturing and Controls information.

Conexiant

May 29, 2026

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

May 05, 2026

Prescribing Outside the Exam Room

A DEA case exposes how controlled substances can move outside clinical oversight.

Conexiant

Daily News

Stay up to date with the latest clinical headlines and other information tailored to your specialty.

April 30, 2026

Urgent Care, Unchecked Power

An unsupervised clinic model and blurred boundaries expose how oversight can fail in outpatient care.

Conexiant

April 30, 2026

FDA Approves Auvelity for Agitation in Alzheimer’s Disease

The oral combination therapy expands treatment options for agitation associated with dementia due to Alzheimer’s disease.

Conexiant

April 29, 2026

FDA Updates Lumateperone Label With Relapse-Prevention Data

Label update incorporates randomized withdrawal trial findings showing delayed time to relapse and consistent safety profile in schizophrenia

Conexiant

April 29, 2026

FDA Monthly Preview: Key May Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Conexiant

April 21, 2026

Two-Drug HIV Regimen Gains FDA Approval

Phase 3 trials showed noninferior viral suppression vs standard three-drug therapy with similar safety outcomes

Conexiant

ADHD Drug CTx-1301 Receives Complete Response Letter

FDA & Government News

HHS Seeks Broader Access to Health Data

Hospital AI Fails to Flag Drug Diversion

ADHD Drug CTx-1301 Receives Complete Response Letter

FDA Monthly Preview: Key June Decisions to Watch

Prescribing Outside the Exam Room

Daily News

Urgent Care, Unchecked Power

FDA Approves Auvelity for Agitation in Alzheimer’s Disease

FDA Updates Lumateperone Label With Relapse-Prevention Data

FDA Monthly Preview: Key May Decisions to Watch

Two-Drug HIV Regimen Gains FDA Approval

Recommendations

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Surgical Techniques to Remove Subretinal Perfluoro-n-Octane

Trending Now

ADHD Drug CTx-1301 Receives Complete Response Letter

Trending Now

Find topic & conditions by first letter

Compendium

Inside Dental Hygiene

Inside Dentistry

ADA News

CDE World

New Dentist News

The ASCO Post

JADPRO

JNCCN

JNCCN 360

ASCO AI in Oncology

Glaucoma Physician

Ophthalmology Management

Retinal Physician

The Ophthalmologist

Contact Lens Spectrum

Eyecare Business

Optometric Management

The Pathologist

FDA & Government News

Daily News

Recommendations